BioSpace News Archive

Fact.MR: The global dermocosmetics market is projected to witness healthy growth over the forecast period of 2021-2031.

Urinalysis is analysis of urine sample to diagnose various conditions such as kidney disorders, liver problems, diabetes or other metabolic conditions, and urinary tract infections.

Yesterday, June 23, stem cell biotechnology company Asymmetrex presented its latest advances in stem cell technology to attendees in the 2021 Annual Meeting of the International Society for Stem Cell Research, which runs from June 21-26.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced ahead of this morning’s Virtual Investor and Analyst Day that it anticipates exceeding its previously announced financial guidance for the second quarter ending July 4, 2021, driven by broad-based momentum across both COVID and non-COVID businesses.

ObsEva SA announced the presentation of data from two of its clinical development programs at the European Society of Human Reproduction and Embryology Virtual 37th Annual Meeting, being held June 26 - July 1, 2021.

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to bringing innovative treatments that offer added value to underserved patient populations, announces that it has successfully renegotiated and unwound its earlier license agreements with the Alter Pharma Group.

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has accepted the company’s Biologics License Application, under Priority Review, for Port Delivery System with ranibizumab for the treatment of wet, or neovascular, age-related macular degeneration.

Synthetic drugs are produced in a laboratory employing various chemical reactions. The chemical structure of these synthetic drugs match naturally occurring drugs and they are designed in such as way as to enhance their effects as compared to naturally occurring drugs, or to prevent undesired side effects.

DNA comprises the blueprints of life. Within the structure of DNA, there are codes which are required for the assembly of proteins and non-coding RNA; these molecular machineries are responsible for affecting the biological systems that are creating and maintaining life.

According to the report, the global neuroscience market was valued at US$ 28.5 Bn in 2020 and is projected to expand at a CAGR of ~4% from 2021 to 2031.